Literature DB >> 26671593

Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic.

Luís Moreno1, Jordi Sánchez-Delgado2, Mercedes Vergara3, Meritxell Casas4, Mireia Miquel5, Blai Dalmau6.   

Abstract

Ciprofloxacin and amoxicillin/clavulanic are two widely used antibiotics due to their high efficacy and few side effects. While the percentage of hepatotoxicity of these antibiotics is low, their frequent use has led to a progressive increase in the number of cases. Both antibiotics have been associated with a wide variety of hepatotoxic reactions, from a slight rise of transaminases to fulminant hepatitis. Once hepatotoxicity secondary to a drug appears, the first step is to discontinue the drug. Physicians may opt to administer an alternative treatment with a different chemical structure. It should be borne in mind, however, that different chemical structures may also cause recurrent drug-induced liver injuries (DILI). We present the case of a patient who consecutively developed DILI due to ciprofloxacin and amoxicillin/clavulanic.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26671593     DOI: 10.17235/reed.2015.3810/2015

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  4 in total

Review 1.  Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.

Authors:  Milan Radovanovic; Tetyana Dushenkovska; Ivan Cvorovic; Natasa Radovanovic; Vimala Ramasamy; Katarina Milosavljevic; Jelena Surla; Mladen Jecmenica; Miroslav Radulovic; Tamara Milovanovic; Igor Dumic
Journal:  Am J Case Rep       Date:  2018-09-29

2.  Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study.

Authors:  Hong-Yi Yang; Dai-Hong Guo; Wang-Ping Jia; Man Zhu; Yuan-Jie Xu; Xiao-Yu Wang
Journal:  Ther Clin Risk Manag       Date:  2019-03-08       Impact factor: 2.423

Review 3.  Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.

Authors:  Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

4.  Acute Immunoallergic Hepatitis in the Presence of Crohn's Disease: A Case Presentation and Review of the Literature.

Authors:  Brianna R Taylor; Kwame Opoku; Izi Obokhare
Journal:  Cureus       Date:  2022-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.